+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Small Scale Bioreactors Market, by Product Type By Capacity, By End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 196 Pages
  • December 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5523270
Bioreactors are processing vessels used for providing effective environment for enzymes or cells during biochemical processing which involves biological active substances and microorganisms. The bioreactor processes are aerobic or anaerobic. There are various types of bioreactors such as Glass bioreactors, carbon steel bioreactors, stainless steel bioreactors, ceramic bioreactors, and PTFE plastic bioreactors are all cylindrical constructions that come in a variety of sizes and capacities. As the pharmaceutical industries increased efforts to create vaccinations or medications where bioreactors are used in vaccine production, it can be employed for static culture or roller bottle technology. Bioreactors inject sterile gas such as oxygen and carbon dioxide into the culture medium throughout the manufacturing process. Constant stirring disperses the nutrients and lowers the size of gas bubbles formed by the sterile gas supply in the culture vessel, allowing oxygen to enter the nutrient solution.



Market Dynamics


Market players are indulged in research and development activities which is expected to increase the growth of the global small scale bioreactors market over the forecast period. For instance, according to article published in the journal Frontiers in Bioengineering and Biotechnology, August 2020, researchers of University College of London, U.K. conducted the study to review Small-Scale Fluidized Bed Bioreactor (sFBB) for Long-Term Dynamic Culture of 3D Cell Constructs and in vitro Testing. The results of the study demonstrated that sFBB serve as a device for long-term culture and analysis of 3D cell constructs with prospects of engineering in vitro models, which could more closely reproduce the in vivo conditions and in a more cost-effective manner, and ultimately contribute towards reducing the use of animal models in research.

Increasing number of inorganic growth strategies such as collaborations of key players in the regions such as North America, Europe, and Asia pacific is expected to drive the growth of small scale bioreactors market over the forecast period. For instance, in August 2020, Pluristem Therapeutics Inc., a regenerative medicine company, announced that its subsidiary, Pluristem Ltd., had signed a non-binding Memorandum of Understanding (MOU) with the United Arab Emirates-based Abu Dhabi Stem Cells Center (ADSCC), a specialist healthcare center focused on cell therapy and regenerative medicine. Under this collaboration, the company and the healthcare center will work for the development of cell therapies and regenerative medicines for the treatment of severe diseases including COVID-19

Key features of the study:

  • This report provides an in-depth analysis of global small scale bioreactors market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global small scale bioreactors market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include Merck KGaA, Danaher Corporation, Getinge AB, Sartorius AG ,Thermo Fisher Scientific Inc. , Lonza Group , Eppendorf AG , Miltenyi Biotec ,Solaris Biotechnology Srl, Infors AG, Biosan, MicroDigital Co. Ltd., 2mag AG, MDX Biotechnik International GmbH, Esco Lifesciences Group, HiTec Zang GmbH, Hanil Scientific Inc., Adolf Kühner AG, Ori Biotech, Aglaris and AdvaBio.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global small scale bioreactors market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small scale bioreactors market

Detailed Segmentation:


Global Small Scale Bioreactors Market, By Product Type:

  • Reusable Bioreactors
  • Stainless Steel Bioreactors
  • Glass Bioreactors
  • Single-use Bioreactors

Global Small Scale Bioreactors Market, By Capacity:

  • 5 ML -100 ML
  • 100 ML-250 ML
  • 250 ML -500 ML
  • 500 ML-1 L
  • 1L-3L
  • 3L-5L

Global Small Scale Bioreactors Market, By End User:

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Research Organizations

Global Small Scale Bioreactors Market, By Region:

  • North America- U.S.
  • Canada
  • Latin America- Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe- U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific- Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Middle East- GCC
  • Israel
  • Rest of Middle East
  • Africa

By Country/Region:

  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Lonza Group
  • Eppendorf AG
  • Miltenyi Biotec
  • Getinge AB
  • Solaris Biotechnology Srl
  • Infors AG
  • Biosan
  • MicroDigital Co., Ltd.
  • 2mag AG
  • MDX Biotechnik International GmbH
  • Esco Lifesciences Group
  • HiTec Zang GmbH
  • Hanil Scientific Inc.
  • Adolf Kühner AG
  • Ori Biotech
  • Aglaris
  • AdvaBio
Frequently Asked Questions about the Small Scale Bioreactors Market

What is the estimated value of the Small Scale Bioreactors Market?

The Small Scale Bioreactors Market was estimated to be valued at $1233.5 Million in 2021.

What is the growth rate of the Small Scale Bioreactors Market?

The growth rate of the Small Scale Bioreactors Market is 10.6%, with an estimated value of $2494.8 Million by 2028.

What is the forecasted size of the Small Scale Bioreactors Market?

The Small Scale Bioreactors Market is estimated to be worth $2494.8 Million by 2028.

Who are the key companies in the Small Scale Bioreactors Market?

Key companies in the Small Scale Bioreactors Market include Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza Group, Eppendorf AG, Miltenyi Biotec, Getinge AB and Infors AG.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Capacity
  • Market Snippet, By End User
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Recent Product Launch/Approval
  • Epidemiology
  • Mergers and Acquisitions

4. COVID - 19 Impact Analysis
  • Impact on Supply Chain
  • Impact on Research and Development
  • Government Initiatives

5. Global Small Scale Bioreactors Market, By Product Type, 2017-2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Reusable Bioreactors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Stainless Steel Bioreactors
  • Glass Bioreactors
  • Single-use Bioreactors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)

6. Global Small Scale Bioreactors Market, By Capacity, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • 5 ML -100 ML
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • 100 ML-250 ML
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • 250 ML-500 ML
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • 500 ML-1 L
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • 1 L-3L
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • 3L-5 L
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)

7. Global Small Scale Bioreactors Market, By End User, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Contract Manufacturing Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)

8. Global Small Scale Bioreactors Market, By Region, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
  • Regional Trends
  • North America
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Capacity, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Capacity, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Capacity, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Capacity, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Capacity, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Capacity, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape
  • Company Profiles
  • Merck KGaA
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Danaher Corporation
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Getinge AB
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Sartorius AG
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Thermo Fisher Scientific Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Lonza Group
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Eppendorf AG
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Miltenyi Biotec
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Solaris Biotechnology Srl
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Infors AG
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Biosan
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • MicroDigital Co., Ltd.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • 2mag AG
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • MDX Biotechnik International GmbH
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Esco Lifesciences Group
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • HiTec Zang GmbH
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Hanil Scientific Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Adolf Kühner AG
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Ori Biotech
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Aglaris
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • AdvaBio
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views

10. Section
  • References
  • Research Methodology

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Lonza Group
  • Eppendorf AG
  • Miltenyi Biotec
  • Getinge AB
  • Solaris Biotechnology Srl
  • Infors AG
  • Biosan
  • MicroDigital Co., Ltd.
  • 2mag AG
  • MDX Biotechnik International GmbH
  • Esco Lifesciences Group
  • HiTec Zang GmbH
  • Hanil Scientific Inc.
  • Adolf Kühner AG
  • Ori Biotech
  • Aglaris
  • AdvaBio